ESALF
Price
$30.75
Change
-$1.25 (-3.91%)
Updated
Aug 26 closing price
Capitalization
8.79B
SHPH
Price
$3.32
Change
-$0.02 (-0.60%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
3.55M
Interact to see
Advertisement

ESALF vs SHPH

Header iconESALF vs SHPH Comparison
Open Charts ESALF vs SHPHBanner chart's image
Eisai
Price$30.75
Change-$1.25 (-3.91%)
Volume$300
Capitalization8.79B
Shuttle Pharmaceuticals Holdings
Price$3.32
Change-$0.02 (-0.60%)
Volume$200
Capitalization3.55M
ESALF vs SHPH Comparison Chart in %
Loading...
ESALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESALF vs. SHPH commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESALF is a StrongBuy and SHPH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ESALF: $30.75 vs. SHPH: $3.34)
Brand notoriety: ESALF and SHPH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ESALF: 10% vs. SHPH: 10%
Market capitalization -- ESALF: $8.79B vs. SHPH: $3.55M
ESALF [@Pharmaceuticals: Generic] is valued at $8.79B. SHPH’s [@Pharmaceuticals: Generic] market capitalization is $3.55M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESALF’s FA Score shows that 2 FA rating(s) are green whileSHPH’s FA Score has 0 green FA rating(s).

  • ESALF’s FA Score: 2 green, 3 red.
  • SHPH’s FA Score: 0 green, 5 red.
According to our system of comparison, ESALF is a better buy in the long-term than SHPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESALF’s TA Score shows that 5 TA indicator(s) are bullish while SHPH’s TA Score has 5 bullish TA indicator(s).

  • ESALF’s TA Score: 5 bullish, 5 bearish.
  • SHPH’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SHPH is a better buy in the short-term than ESALF.

Price Growth

ESALF (@Pharmaceuticals: Generic) experienced а -4.47% price change this week, while SHPH (@Pharmaceuticals: Generic) price change was +0.76% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.00%. For the same industry, the average monthly price growth was +11.42%, and the average quarterly price growth was +84.24%.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.00% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESALF($8.79B) has a higher market cap than SHPH($3.56M). ESALF YTD gains are higher at: 19.696 vs. SHPH (-84.470). ESALF has higher annual earnings (EBITDA): 104B vs. SHPH (-11.67M). ESALF has more cash in the bank: 266B vs. SHPH (4.82M). SHPH has less debt than ESALF: SHPH (713K) vs ESALF (188B). ESALF has higher revenues than SHPH: ESALF (789B) vs SHPH (0).
ESALFSHPHESALF / SHPH
Capitalization8.79B3.56M247,370%
EBITDA104B-11.67M-890,886%
Gain YTD19.696-84.470-23%
P/E Ratio27.69N/A-
Revenue789B0-
Total Cash266B4.82M5,520,963%
Total Debt188B713K26,367,461%
FUNDAMENTALS RATINGS
ESALF: Fundamental Ratings
ESALF
OUTLOOK RATING
1..100
94
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
6
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ESALFSHPH
RSI
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
44%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 28 days ago
38%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ESALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TRPA39.07N/A
+0.01%
Hartford AAA CLO ETF
FDTS53.13N/A
N/A
First Trust DevMkts exUS SC AlphaDEX®ETF
VETZ19.92N/A
N/A
Academy Veteran Impact ETF
BSTZ21.80-0.05
-0.23%
BlackRock Science and Technology Term Trust
AGGH20.60-0.05
-0.24%
Simplify Aggregate Bond ETF

ESALF and

Correlation & Price change

A.I.dvisor tells us that ESALF and ESAIY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESALF and ESAIY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESALF
1D Price
Change %
ESALF100%
N/A
ESAIY - ESALF
26%
Poorly correlated
-0.64%
DVAX - ESALF
23%
Poorly correlated
-1.72%
KHTRF - ESALF
22%
Poorly correlated
N/A
SHPH - ESALF
22%
Poorly correlated
-2.20%
BLMH - ESALF
21%
Poorly correlated
-3.91%
More

SHPH and

Correlation & Price change

A.I.dvisor tells us that SHPH and LFCR have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPH and LFCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHPH
1D Price
Change %
SHPH100%
-2.20%
LFCR - SHPH
31%
Poorly correlated
+0.40%
PLSH - SHPH
25%
Poorly correlated
N/A
YCBD - SHPH
22%
Poorly correlated
-2.11%
ESALF - SHPH
22%
Poorly correlated
N/A
TKNO - SHPH
21%
Poorly correlated
-2.63%
More